What does Children's Tumor Foundation Europe do?

Children's Tumor Foundation Europe is filed with the CBE under the catch-all “Verenigingen op het vlak van ziektepreventie en gezondheidsbevordering”, a code that says little about what the company actually does. Public Foundation, started on 23 October 2018, 1 establishment.

What is the address of Children's Tumor Foundation Europe?

The registered office of Children's Tumor Foundation Europe is located at Sint-Lazaruslaan 4-10 box 6éme, 1210 Sint-Joost-ten-Node.

Is Children's Tumor Foundation Europe still active?

Yes. According to the CBE (31 October 2026) Children's Tumor Foundation Europe is active, legal situation “Normale toestand”, started on 23 October 2018.

Is Children's Tumor Foundation Europe registered on Peppol?

Yes, Children's Tumor Foundation Europe is registered on the Peppol network with ID 0208:0711985938.

What is the enterprise number of Children's Tumor Foundation Europe?

The enterprise number of Children's Tumor Foundation Europe is BE0711985938.

When was Children's Tumor Foundation Europe founded?

Children's Tumor Foundation Europe was founded on 23 October 2018.

Who are the directors of Children's Tumor Foundation Europe?

According to the 2024 annual accounts, the directors of Children's Tumor Foundation Europe are: Simone MANSO, Sissy Marie-Caroline WINDISCH GEB. MULLER, Magda CHLEBUS, Samia ARSLANE, Nikola GAZDOV, Sabine MORAVI, Stuart Match SUNA, Annette BAKKER.

Is Children's Tumor Foundation Europe a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 23 October 2018; 4 annual accounts filed, latest fiscal year 2024; 9 directors known from the annual account.

How much profit did Children's Tumor Foundation Europe make in 2024?

Children's Tumor Foundation Europe recorded a loss after taxes of € 25,611 in financial year 2024.

What is the revenue of Children's Tumor Foundation Europe?

As a small company, Children's Tumor Foundation Europe is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € -17,982.

Children's Tumor Foundation Europe (Public Foundation)

Dossier Children's Tumor Foundation Europe, printed on 1 November 2026 from databakkes.be/en/0711985938/children-s-tumor-foundation-europe. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Busy address KBO

104 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2024

Children's Tumor Foundation Europe from Sint-Joost-ten-Node, company number BE0711985938, closed financial year 2024 with a result of € -25,611 after tax. For that financial year Children's Tumor Foundation Europe recorded a gross margin of € -17,982 and equity of € 58,474. Compared with financial year 2023, the result moved from € 70 to € -25,611. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 24, 2025.

What it is worth Healthy

€ 58,474

▼ 30% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -25,611

▼ still € 70 profit in 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 96,614

▼ 29% vs 2023

Cash and bank balances on the last day of the fiscal year.

Debts at end 2024

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,305

▼ 95% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 4,311

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 42,711 Gross margin 2021: € 42,711 First fiscal year in the series	€ 16,714 Gross margin 2022: € 16,714 ▼ 61% vs 2021 (€ 42,711) Unfavourable step	€ 7,817 Gross margin 2023: € 7,817 ▼ 53% vs 2022 (€ 16,714) Unfavourable step	€ -17,982 Gross margin 2024: € -17,982 ▼ € 25,799 vs 2023 (€ 7,817) Unfavourable step	▼ € 25,799
Profit after taxes	€ 35,225 Profit after taxes 2021: € 35,225 First fiscal year in the series	€ 10,149 Profit after taxes 2022: € 10,149 ▼ 71% vs 2021 (€ 35,225) Unfavourable step	€ 70 Profit after taxes 2023: € 70 ▼ 99% vs 2022 (€ 10,149) Unfavourable step	€ -25,611 Profit after taxes 2024: € -25,611 ▼ € 25,681 vs 2023 (€ 70) Unfavourable step	▼ € 25,681
Equity	€ 73,867 Equity 2021: € 73,867 First fiscal year in the series	€ 84,016 Equity 2022: € 84,016 ▲ 14% vs 2021 (€ 73,867) Favourable step	€ 84,085 Equity 2023: € 84,085 Unchanged (€ 84,016) Favourable step	€ 58,474 Equity 2024: € 58,474 ▼ 30% vs 2023 (€ 84,085) Unfavourable step	▼ 30%
Total debts	€ 280,376 Total debts 2021: € 280,376 First fiscal year in the series	€ 106,151 Total debts 2022: € 106,151 ▼ 62% vs 2021 (€ 280,376) Favourable step	€ 56,891 Total debts 2023: € 56,891 ▼ 46% vs 2022 (€ 106,151) Favourable step	€ 39,944 Total debts 2024: € 39,944 ▼ 30% vs 2023 (€ 56,891) Favourable step	▼ 30%
Cash	€ 220,755 Cash 2021: € 220,755 First fiscal year in the series	€ 85,338 Cash 2022: € 85,338 ▼ 61% vs 2021 (€ 220,755) Unfavourable step	€ 136,013 Cash 2023: € 136,013 ▲ 59% vs 2022 (€ 85,338) Favourable step	€ 96,614 Cash 2024: € 96,614 ▼ 29% vs 2023 (€ 136,013) Unfavourable step	▼ 29%
Retained profit	€ 60,941 Retained profit 2021: € 60,941 First fiscal year in the series	€ 71,090 Retained profit 2022: € 71,090 ▲ 17% vs 2021 (€ 60,941) Favourable step	€ 71,159 Retained profit 2023: € 71,159 Unchanged (€ 71,090) Favourable step	€ 45,548 Retained profit 2024: € 45,548 ▼ 36% vs 2023 (€ 71,159) Unfavourable step	▼ 36%
Balance sheet total	€ 354,243 Balance sheet total 2021: € 354,243 First fiscal year in the series	€ 190,167 Balance sheet total 2022: € 190,167 ▼ 46% vs 2021 (€ 354,243) Unchanged	€ 140,976 Balance sheet total 2023: € 140,976 ▼ 26% vs 2022 (€ 190,167) Unchanged	€ 98,418 Balance sheet total 2024: € 98,418 ▼ 30% vs 2023 (€ 140,976) Unchanged	▼ 30%

Key figures of Children's Tumor Foundation Europe, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to Children's Tumor Foundation Europe?

What happened at Children's Tumor Foundation Europe in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2030 Simone MANSO stepped down as director. NBB
2030 Sissy Marie-Caroline WINDISCH GEB. MULLER stepped down as director. NBB
2030 Magda CHLEBUS stepped down as director. NBB
2030 Samia ARSLANE stepped down as director. NBB
2030 Nikola GAZDOV stepped down as director. NBB
2030 Sabine MORAVI stepped down as director. NBB
2030 Stuart Match SUNA stepped down as director. NBB
2030 Annette BAKKER stepped down as director. NBB

In short

From € 35,225 profit in 2021 to € 25,611 loss in 2024.

Best year ever: 2021, with € 35,225 profit.

Original PDFs at the National Bank ↗

Management

Directors

According to the 2024 annual accounts

Simone MANSO

Director

since 2019 · until 2030

Sissy Marie-Caroline WINDISCH GEB. MULLER

Director

since 2022 · until 2030

Magda CHLEBUS

Director

since 2019 · until 2030

Samia ARSLANE

Director

since 2022 · until 2030

Nikola GAZDOV

Director

since 2020 · until 2030

Sabine MORAVI

Director

since 2023 · until 2030

Stuart Match SUNA

Director

since 2018 · until 2030

Annette BAKKER

Director

since 2018 · until 2030

Richard HORVITZ

Director

since 2018 · until 2030

Establishments

Establishment units

Physical locations of this company

Registered office

Sint-Lazaruslaan 4-10 box 6éme

1210 Sint-Joost-ten-Node

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 104 companies are registered at this address.

All companies at this address →

Energia

€ 970,536 gross margin · 2025

Aurorium Belgium 2

€ 9.5 million revenue · 2025

HASBRO BELGIUM

€ 658,256 gross margin · 2025

Agra CEAS CONSULTING-Bureau Européen de Recherches

€ 2.2 million gross margin · 2024

BMC Software Belgium

€ 2 million gross margin · 2026

+99 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0711.985.938
VAT number: BE 0711.985.938
Registered office: Sint-Lazaruslaan 4-10 bus 6éme, 1210 Sint-Joost-ten-Node
Names & denominations: Children's Tumor Foundation Europe · CTF Europe
Enterprise type: Rechtspersoon
Legal form: Public-interest foundation
Legal situation: Normale toestand
Start date: 23 October 2018
Peppol: Active · Active since 3 Dec 2025
Activities · NACE: Verenigingen op het vlak van ziektepreventie en gezondheidsbevordering

View on CBE Public ↗ Annual accounts (NBB) ↗

Children's Tumor Foundation Europe

Warning lights

Financials

What happened to Children's Tumor Foundation Europe?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions